Working… Menu

Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide After Renal Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04530630
Recruitment Status : Recruiting
First Posted : August 28, 2020
Last Update Posted : November 23, 2020
Gilead Sciences
Information provided by (Responsible Party):
Weill Medical College of Cornell University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : December 2022
Eron JJ, Lelievre J-D, Kalayjian R, Slim J, et al. Safety and Efficacy of E/C/F/TAF in HIV-Infected Adults on Chronic Hemodialysis (Abstract, poster 732 presented at CROI 2018).